|
Mr. Frank attended received his MBA from Stanford in 1958 and began his Wall Street career. Frederick Frank is vice chairman and a director of Lehman Brothers, Inc. Before joining Lehman Brothers as a partner in October, 1969, he was co-director of research, as well as vice president and director, of Smith, Barney & Co. Inc. He is a chartered financial analyst, a member of The New York Society of Security Analysts and a past president of the Chemical Processing Industry Analysts. Mr. Frank graduated from the Hotchkiss School in 1950 and from Yale University in 1954. He then spent two years in the Army, most of the time stationed with Supreme Headquarters Allied Powers Europe (SHAPE) in Paris. In addition to serving as a director of business engine, Diagnostic Products Corporation, Digital Arts & Sciences, Inc., eSoft, Incorporated, Landec Corporation, Pharmaceutical Product Development, Inc., and Predix Pharmaceuticals, he is chairman of the National Genetics Foundation, a director of the Salk Institute, former president of the board and currently trustee emeritus of The Hotchkiss School, a member of the Yale School of Organization and Management Advisory Board, a member of the Pharmaceutical Executive Magazine advisory board, a member of the Board of Governors of the National Center for Genome Resources, Chairman of the Board of The Irvington Institute for Immunological Research, a Director of the Institute for Systems Biology and an Advisory Board Member of The Johns Hopkins Bloomberg School of Public Health, a member of the Dean's Council of The Harvard School of Public Health, and an Advisory Board Member of the MIT Center for BioMedical Innovation. Mr. Frank has provided investment banking services to a host of companies in the pharmaceutical, biotechnology, healthcare service providers, medical device nutraceutical, and high technology industries. He has been involved in hundreds of financings and merger and acquisition transactions in the health care field. | 